Stockwinners Market Radar for May 25, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

17:37 EDT Post Holdings reports fire in Michael Foods' plant in Pennsylvania - Post Holdings reported a fire took place on the evening of May 24 at its Michael Foods plant location in Klingerstown, PA. All employees were safely evacuated and no injuries were reported. The cause of the fire, which started in the duct work of an oven, is being investigated. The financial impact of the fire is expected to be insured to the extent it exceeds $2.5M, however, costs may be incurred in different reporting periods than any insurance recovery.

17:24 EDT PRA Health to replace Abiomed in the S&P 400 at open on May 31st

17:21 EDT ABIOMED to replace Wyndham in the S&P 500 at open on May 31st

17:06 EDT Windstream completes one-for-five reverse stock split - Windstream completed its previously announced one-for-five reverse stock split following market close. Windstream stockholders approved the reverse split and share count reduction at the company's annual meeting on May 21. As a result, the authorized shares of common stock decreased from 375,000,000 shares to 75,000,000 shares and the number of authorized shares of preferred stock decreased from 33,333,333 shares to 6,666,667 shares. Actual total shares outstanding decreased from approximately 200M shares to approximately 40M shares.

16:36 EDT Rent-A-Center 16.8% shareholder Engaged Capital nominates Carol McFate to Board - On May 25, 2018, Engaged Capital and certain of its affiliates entered into a letter agreement with Rent-A-Center in connection with that certain Cooperation Agreement between Engaged and the Issuer. In accordance with the Cooperation Agreement, Engaged proposed Carol McFate to be nominated for election to the Board of Directors at the 2018 annual meeting of stockholders and the Board confirmed her qualifications to serve on the Board. In light of the Board's continuing review of strategic and financial alternatives to maximize stockholder value, Engaged elected to waive, pursuant to the Letter Agreement, its right under the Cooperation Agreement to put forth Ms. McFate as a potential director nominee for election at the 2018 Annual Meeting. In exchange for the waiver, at any time prior to the termination of the Cooperation Agreement, Engaged may put forth Ms. McFate as a potential director nominee for election or appointment to the Board.

16:31 EDT Ditech discloses receipt of late filing notice from NYSE - Ditech Holding announced that it has received a late filing notice from the New York Stock Exchange indicating that the company is not in compliance with the NYSE's continued listing requirements under the timely filing criteria in Section 802.01E of the NYSE Listed company Manual as a result of the company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2018. As reported by the company in its Form 12b-25 filed with the Securities and Exchange Commission on May 16, 2018, the company was unable to file its Form 10-Q within the prescribed time period without unreasonable effort or expense due to various factors, such as the timing of the filing of the company's Form 10-K for the fiscal year ended December 31, 2017, as well as certain accounting and financial reporting matters, including the application of fresh start accounting in connection with the company's emergence from Chapter 11 Bankruptcy on February 9, 2018, which resulted in the company requiring additional time to complete its financial closing procedures and, as a result, its independent registered public accounting firm requiring additional time to complete the interim review of the company's consolidated financial statements as of and for the period ended March 31, 2018.

16:11 EDT Fairmount Santrol, Unimin receive final merger approval - Fairmount Santrol and Unimin Corporation announced that they have received the regulatory approvals required to complete their announced merger, including approval from the Mexican Federal Economic Competition Commission. The companies are also pleased to announce the approval by a majority of Fairmount Santrol shareholders at the special shareholder meeting held May 25, 2018. At the time of close, which is expected to be June 1, 2018, the combined company will be named Covia Holdings Corporation and will begin trading on the New York Stock Exchange under the ticker symbol "CVIA".

16:06 EDT CIT Group names Marisa Harney chief risk officer - CIT Group announced that it has named Wahida Plummer as its chief risk officer responsible for all enterprise risk. In addition, the company has promoted its Chief Credit Officer Marisa Harney to an expanded role leading all credit risk. Both leaders will report to CIT Chairwoman and Chief Executive Officer Ellen R. Alemany and serve on the company's Executive Management Committee, effective immediately. CIT's former Chief Risk Officer Robert Rowe has elected to leave the company to pursue other career opportunities and will remain with CIT over the coming weeks to ensure a smooth transition.

15:56 EDT Magellan Health boosts stock repurchase authorization to $400M - In a regulatory filing, Magellan Health reported that the company's board of directors approved an increase of $200M to the current $200M stock repurchase plan, which will now authorize the company to purchase up to $400M of its outstanding common stock. The board also extended the program from October 22, 2018 to October 22, 2020. As of May 24, 2018, the total dollar value remaining under this increased authorization was $245.9M.

13:23 EDT AmTrust: Glass Lewis recommends investors vote for proposed going-private deal - AmTrust Financial Services announced that independent proxy advisory firm Glass Lewis & Co. has recommended that AmTrust stockholders vote "FOR" the company's previously announced merger agreement at the Special Meeting of Stockholders on June 4, 2018. Under the terms of the merger agreement, Evergreen Parent, L.P. will acquire for $13.50 per share in cash the approximately 45% of the company's shares of common stock that the Karfunkel-Zyskind Family and certain of its affiliates and related parties do not already own or control, subject to regulatory approval and other closing conditions.In its May 24, report, Glass Lewis acknowledged that the value achieved in the going-private transaction represents the highest and most certain value available for public stockholders: "Given the rigor of these negotiations and the need to offer Stone Point concessions to accept the deal at $13.50 per share, as well as the absence of any increased offer since Icahn's public involvement in the stock, it does not appear likely that the special committee could extract a higher price. The purchase price falls above or within the valuation ranges derived in the advisor's comparable companies, precedent transactions and dividend discount analyses. The exit price also represents what is, in our view, an attractive premium to the unaffected trading price of AmTrust shares and falls well above the average closing share price over the one-month and three-month periods trailing announcement of the initial offer."

13:01 EDT UPS appoints Kevin Warren Chief Marketing Officer - UPS appointed Kevin Warren to the position of Chief Marketing Officer, effective June 1. Warren will report to UPS Chairman and CEO David Abney. He also joins the UPS Management Committee, the most senior leadership group in the company.

12:31 EDT PepsiCo confirms agreement to acquire Bare Snacks - PepsiCo announced it has entered into a definitive agreement to acquire Bare Foods, a U.S.-based maker of baked fruit and vegetable snacks. The transaction will expand the company's snacking portfolio and further deliver on its Performance with Purpose vision to offer consumers more positive nutrition options. Upon closing, Bare Snacks will continue to operate independently from its headquarters in San Francisco with its leadership reporting into Frito-Lay North America, a division of PepsiCo.

11:56 EDT Gulf Island Fabrication awarded 3300HP towboat newbuild project with option - Gulf Island Fabrication announced that through its Shipyard Division, it has been awarded a newbuild contract for the construction of one 3300-horsepower towboat with one option for another vessel. Delivery of the first vessel is estimated at 12 months after contract execution with delivery of the optional vessel approximately two months after delivery of the first vessel if the option is exercised by the customer.

11:49 EDT Icahn says ISS recommends shareholders vote against AmTrust going-private deal - Carl Icahn issued a statement regarding AmTrust Financial Services, stating in part: "We are very pleased that the very well-regarded Institutional Shareholder Services, Inc., the world's preeminent proxy analysis and voting recommendation firm, has weighed in on the opportunistic AmTrust going-private transaction [and] recommends shareholders vote against the AmTrust going-private transaction. ISS sees the Zyskind/Karfunkel squeeze-out very similarly to how we see things." Reference Link

11:07 EDT Roku rises after Citron's Left makes U-turn, goes long - Andrew Left has reversed course on Roku (ROKU), a name he had previously recommended shorting, sending the stock higher in morning trading. Where previously the Citron Research front man was worried about valuation, he now points to the rally in Netflix (NFLX) as a reason to reconsider that stance and believes the over-the-top, or OTT, viewing "megatrend" can no longer be ignored. NEW CITRON REPORT: In a new report published to Citron's website earlier today, Left noted that Citron previously had called Roku's stock price "a joke" and predicted the shares would trade back to $28. Roku subsequently traded back to $29 and bounced, said Left, who added that the "OTT movement has become a megatrend that cannot be ignored and the numbers around Roku have completely changed since our November 29 tweet." Citron said that Roku is now trading at its "largest discount ever to OTT peers despite being the only OTT pure play that generates ad revenue" and re-evaluating Disney's (DIS) acquisition of DTC streaming service BAMTech with Roku's current subscriber base implies Roku "could be worth about 3x its current value." Left also said the rally in Netflix share price since November has forced him to reevaluate, adding that Roku short interest is four times that of Netflix and "shorts have to know when they overstay their welcome." PRICE ACTION: In late morning trading, Roku has risen $1.76, or 4.9%, to $37.78 per share.

10:25 EDT Herbalife Nutrition drops as Icahn looks to sell part of stake - Shares of Herbalife Nutrition (HLF) plunged in morning trading after Icahn Enterprises (IEP), its largest shareholder, disclosed in a regulatory filing that it is tendering about a quarter of the shares it currently owns. ICAHN LOOKS TO SELL PART OF HERBALIFE STAKE: In a regulatory filing, Carl Icahn's Icahn Enterprises said it is tendering up to 11.4M Herbalife shares, or about a quarter of the 45.7M shares it currently owns. ICAHN COMMENTARY: "For almost six years, we have been one of Herbalife's strongest, most loyal supporters; we stood by the company through a half-decade long short-selling campaign; and we never sold a share, even after our investment doubled," said Icahn Enterprises Chairman Carl Icahn. "But, given that our Herbalife investment has become an outsized position, representing approximately 24% exposure to total NAV, it is only prudent for IEP to reduce its exposure. IEP's investment in Herbalife is a quintessential example of our activist investment strategy," he continued. Icahn also said "We believe Herbalife's business is stable, the short-sellers have largely exited, and the company is well-positioned for the future." Icahn Enterprises first acquired Herbalife shares in late 2017, and said since then, almost $7B of value has been created for Herbalife investors. WHAT'S NOTABLE: In February, Bill Ackman's Pershing Square hedge fund closed out its well-publicized short position. This also ended the high-profile feud with Carl Icahn, who was bullish on the stock. Speaking on CNBC on March 1, Icahn said he thought Ackman would get out of his Herbalife short position sooner, while adding that he put up a "good fight." Icahn also pointed out that he has not sold "one single share" of Herbalife as of that time. PRICE ACTION: Herbalife is down 7.2% to $50.00 in morning trading.

10:01 EDT The Intersection: Crypto and Wall Street This Week - As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly: 1. DOJ OPENS CRIMINAL PROBE: The Justice Department has opened a criminal investigation into whether traders are manipulating the price of bitcoin and other cryptocurrencies, ramping up scrutiny of the markets that critics say are rife with misconduct, Bloomberg reported Thursday. Federal prosecutors are working with the Commodity Futures Trading Commission and the probe is in early stages. The Department is focused on illegal practices that can affect prices such as spoofing, or flooding the market with fake orders to trick other traders into buying and selling, and wash trading, in which a trader trades with himself to give the false impression of market demand. 2. GPU DEMAND SAID TO SLOW: AMD (AMD) and Nvidia (NVDA) could see curbed profitability from the second to fourth quarters of 2018 due to the sudden slowing of cryptocurrency hype causing declining demand for mining GPUs, DigiTimes reported Tuesday. Companies in the two graphic card suppliers' supply chain are likely to see weaker earnings and shipment growth momentum than a year earlier and both AMD and Nvidia previously predicted slower demand for mining graphics cards and revenue declines in the next quarter. 3. OVERSTOCK'S tZERO TO LAUNCH TOKEN EXCHANGE: Overstock (OSTK) subsidiary t0.com and BOX Digital Markets announced a joint venture Tuesday to launch the industry's first regulated security token exchange. On May 18, the two companies entered into a letter of intent to form an exchange to list and publicly trade security tokens for companies that issue, or convert existing stock to, security tokens. The proposed joint venture would be equally owned by tZERO and BOX Digital, with each having equal representation on the board, together with one mutually agreed upon independent director. Lisa Fall, who currently serves as chief executive officer of BOX Digital and as president of BOX Options Exchange would be the CEO of the joint venture. 4. DEUTSCHE BOERSE MULLS CRYPTO PRODUCTS: European exchange company Deutsche Boerse (DBOEY) is reviewing whether to offer cryptocurrency products after U.S. rivals CBOE Global Markets (CBOE) and CME Group (CME) started bitcoin futures last year, Bloomberg reported Wednesday. "Before we move forward with anything like Bitcoin we want to make sure we understand the underlying transaction which isn't the easiest thing to do," said Jeffrey Tessler, the company's head of clients, adding, "We are deep at work with it," but the group is "not at the same stage" as CME. 5. SSC COMMENCES SALES OF DOAI TOKENS: Seven Stars Cloud Group (SSC) announced Wednesday that private and pre-sales of its Digital Oil Asset Index tokens in the Greater China Region commenced on May 18 and will conclude around the end of June with general sales continuing until the end of September. The first sales are taking place in the Greater China Region only and the company is planning a build out to expand its sales scalability with partners in other regions including the Middle East, Southeast Asia, Korea, Japan, Europe and eventually North America. The DOAI tokens are built atop Ethereum, said SSC, which added that it intends to launch three to four additional commodity market related index products and at least one currency market related index product in 2018. 6. RIOT INVESTS IN THE BLOCK CRYPTO: On Thursday, Riot Blockchain (RIOT) announced a strategic investment in The Block Crypto, which is building a community for enthusiasts of blockchain technology and cryptoassets. "The company's investment in The Block will be used to advance its technology and continue building its team," Riot said. CRYPTO STOCK PLAYS: Overstock, DPW Holdings (DPW), Kodak (KODK), Seven Stars Cloud Group, Riot Blockchain, Pareteum (TEUM) and Social Reality (SRAX) are stocks that have been touted, or promoted themselves, as a way to play the crypto theme PRICE ACTION: As of time of writing, bitcoin dropped roughly 7.4% this week to $7,485 in U.S. dollars according to CoinDesk. WANT BITCOIN NEWS ALERTS?: To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter "Bitcoin" into the "Add symbols" box of their portfolios.

09:50 EDT Bottomline Technologies CEO Robert Eberle sells over $900K in company stock - Bottomline Technologies CEO Robert Eberle disclosed in a filing that he had sold 19,591 shares of company stock at an average price of $46.55 per share for a total transaction value of $912,030 on May 23.

09:33 EDT Diana Containerships announces direct continuation time charter contract - Diana Containerships announced that, through a separate wholly-owned subsidiary, it has agreed to extend the present time charter contract with Orient Overseas Container Line Ltd., Hong Kong, for one of its Post-Panamax container vessels, the m/v Pucon. The gross charter rate is $18,000 per day, minus a 3.75% commission paid to third parties, for a period of minimum eight months to maximum twelve months. The new charter period will commence on June 22, 2018. The m/v Pucon is currently chartered, as previously announced, at a gross charter rate of $10,750 per day, minus a 3.75% commission paid to third parties. The "Pucon" is a 6,541 TEU container vessel built in 2006. The employment extension of "Pucon" is anticipated to generate approximately $4.32 million of gross revenue for the minimum scheduled period of the time charter extension.

09:29 EDT Foot Locker sees FY19 comps flat to up low single digits

09:24 EDT Foot Locker sees Q2 gross margins up 20-50bps

09:23 EDT BrainStorm says currently assessing 'Right-To-Try' legislation - BrainStorm Cell Therapeutics issues a statement following Congress passing the Federal "Right-to-Try" bill. The "Right-to-Try" bill will enable terminally ill patients who do not meet clinical trial criteria to seek out experimental therapies that do not yet have approval by the US Food and Drug Administration. Chaim Lebovits, president and CEO, said,"BrainStorm understands the serious unmet medical need and urgency of people living with ALS. We have received countless inquiries after the passing of Federal 'Right-to-Try' legislation about patient access to NurOwn. We have been, and will continue to, be engaged and collaborate with people with ALS, their families and caregivers, and legislators and government agencies to ensure that the voices of these groups are heard in this important discussion. Brainstorm is currently assessing the legislation and its potential implications, and when signed into law, will issue a formal policy on 'Right-to-Try' in early June. BrainStorm remains focused and fully committed to completing the Phase 3 clinical trial of NurOwn as quickly as possible. While we continually evaluate ways to provide access to NurOwn outside of the current Phase 3 trial to the many patients who can't wait, the most expedient way to make NurOwn available to all is by completing the necessary clinical trial data collection and endpoint analyses, and submitting the required marketing applications without delay to regulatory agencies, including the FDA."

09:08 EDT Centene's Coordinated Care selected for Medicaid contract - Centene Corporation announced its Washington subsidiary, Coordinated Care, has been selected by the Washington State Health Care Authority to provide managed care services to Apple Health's Integrated Managed Care Medicaid beneficiaries in five Regional Service Areas. The RSAs include King, Pierce, North Sound, Greater Columbia, and North Central Region. These contracts will result in the integration of physical and behavioral health.

08:52 EDT On The Fly: Pre-market Movers - HIGHER: Amarin (AMRN), up 3.6% after announcing a settlement agreement that resolves Amarin's previously reported Vascepa patent litigation as it relates to Teva Pharmaceuticals' (TEVA) abbreviated new drug application... BioMarin (BMRN), up 3% after it received approval from the FDA for Palynziq Injection. UP AFTER EARNINGS: Foot Locker (FL), up 15%... Deckers Brands (DECK), up 4%. DOWN AFTER EARNINGS: Gap (GPS), down 7.5%.... Hibbett Sports (HIBB), down 12%... Zoe's Kitchen (ZOES), down 29%... 8x8, Inc. (EGHT), down 9%... Autodesk (ADSK), down 5%... Splunk (SPLK), down 3%. ALSO LOWER: Cincinnati Bell (CBB), down 1.5% after Morgan Stanley analyst Simon Flannery downgraded Cincinnati Bell to Underweight from Equal Weight.

08:47 EDT Herbalife Nutrition announces preliminary results of self-tender offer - Herbalife Nutrition announced the preliminary results of its "modified Dutch auction" tender offer, which expired May 24 to purchase up to an aggregate of $600M of the company's common shares at a cash purchase price not greater than $54.00 nor less than $49.00 per share. Based on the preliminary count by Computershare Trust, the depositary for the tender offer, a total of approximately 49.7M common shares of the company were properly tendered and not properly withdrawn at or below the price of $52.50 per share. In accordance with the terms and conditions of the tender offer and based on a preliminary count by the depositary, the company expects to accept for payment a total of approximately 11.4M common shares of the company at a cash purchase price of $52.50 per share, for a total cash cost of approximately $600M, excluding fees and expenses relating to the tender offer. These common shares represent approximately 6.5% of the company's total outstanding shares as of May 23. Because the tender offer is oversubscribed, the company expects to purchase only a prorated portion of the common shares properly tendered by each tendering shareholder at the final per share purchase price. Based on the preliminary tender count, and accounting for the effect of "odd lot" priority on the proration factor, the depositary has informed the company the preliminary proration factor for the tender offer is expected to be approximately 23% of the shares properly tendered at or below the cash purchase price of $52.50 per share and not properly withdrawn based on the total number of shares reported to be tendered at or below $52.50 per share and not withdrawn prior to the expiration of the tender offer and accounting for "odd lot" priority and the conditional tender provisions of the tender offer. This preliminary proration factor is subject to change.

08:34 EDT USANA clinical sciences team to be led by Rolando Maddela, Jessie Johnson - USANA is announcing a new, centralized plan on the design and management of product-related, preclinical and clinical studies. These new processes will be put in place for the design and execution of all new studies, to meet and exceed the highest standards in our industry. The new clinical sciences team at USANA will be led by Rolando Maddela, MD, MPH. and Jessie Johnson, Ph.D. The team is charged with the design, and overall strategy of USANA clinical studies. Mark Levy, Ph.D., will also continue his role of working with the research and development department on clinical studies. Lawry Han, Ph.D., is a new addition to the department and brings experience in designing and conducting human clinical studies. Both Dr. Levy and Dr. Han will report directly to Dr. Maddela going forward. Product-related, preclinical and clinical studies play a vital role in determining what structure function claims can be supported by reasonable science, which are then reviewed USANA's legal department to satisfy government regulations.

07:44 EDT TrendForce says China's Ministry of Commerce to investigate DRAM manufacturers - China's Anti-Monopoly Bureau of Ministry of Commerce held a meeting with representatives from Micron Technology (MU) to express concerns about the continuing price increase for PC DRAM products over the past quarters.The rising prices have made Chinese PC-OEMs struggling under component cost pressure. In addition, Micron had previously interfered with the supplying of upstream equipment to JHICC in contravention to the spirit of fair competition, says DRAMeXchange, a division of TrendForce. Samsung (SSNLF), SK Hynix and Micron have gained a total market share of 96% in 1Q18, reflecting the current oligopoly in DRAM market compared with the markets of other semiconductor components. Therefore, DRAMeXchange anticipates that such anti-trust investigations may happen again, which may restrain the price increase. According to DRAMeXchange, the top three suppliers - Samsung, SK Hynix and Micron - took shares of 44.9%, 27.9%, and 22.6% respectively in the DRAM market, reflecting the current oligopoly. The anti-monopoly regulations of China aims to ensure fair competition in the market, so that no single supplier becomes too dominant in a market and manipulates the prices. On the other hand, the production cycle of DRAM is more than eight weeks; and it takes at least one year for the CAPEX to turn into new production capacity so that suppliers can increase the chip output. Therefore, DRAM manufacturers are most likely to be investigated due to "limiting the amount of products for sale" in the antitrust laws. Reference Link

07:36 EDT Neovasc provides highlights on Tiara, Reducer at EuroPCR - Neovasc provided highlights from EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. Neovasc management held numerous discussions throughout EuroPCR with European physicians regarding their interest in either participating in the ongoing Tiara clinical trials or in using the Neovasc Reducer product for their patients suffering from refractory angina. "We had a successful and engaging meeting with investigators in our Tiara-II trial regarding clinical results to-date, optimal screening process, best practices for implantation, and a direct comparison of published Tiara clinical results with results from mitral clipping procedures," commented Fred Colen, Neovasc's CEO. Dr. Anson Cheung also presented the latest clinical results of the Tiara valve during the Mitral Valve Replacement session, noting that 56 patients had been implanted to date and the 30-day survival rate was 94%, with trace or no remaining mitral regurgitation in most cases. Dr. Stefan Verheye and Dr. Shmuel Banai hosted a symposium on the Reducer, which included presentations from physicians on their clinical experience with Reducer, discussions about potential additional applications for Reducer, and a cost/benefit analysis of Reducer utilizations for healthcare systems. The scheduled live case of a Reducer implant did not take place as planned because the patient was feeling better and withdrew from the procedure

07:21 EDT Aetna expands agreement making LabCorp a preferred laboratory for Aetna members - Aetna (AET) and LabCorp (LH) extended and expanded their existing agreement, making LabCorp a preferred national laboratory for substantially all of Aetna's members beginning January 1, 2019. The expanded agreement will provide more than 20M eligible members with in-network access to LabCorp's full range of laboratory services. LabCorp is already an in-network laboratory for several million members of Aetna and Aetna-affiliated health plans in certain markets across the U.S. Aetna plan participants will benefit from LabCorp's "scientific expertise", technology and integrated data to help improve the delivery of care. LabCorp offers nearly 5,000 frequently requested and specialty tests, including a wide range of clinical, anatomic pathology, genetic, and genomic tests, delivered through LabCorp's broad patient access points, including a growing retail presence. LabCorp also offers a suite of patient-facing tools, including its new mobile app that allows customers to make appointments, receive results and pay invoices from their handheld devices. In addition, LabCorp offers physicians and patients the opportunity to participate in clinical studies through its Covance Drug Development business, helping to identify and bring new treatments to market.

07:03 EDT Aurora Cannabis retains KCSA for U.S. investor relations efforts - Aurora Cannabis announced it has appointed retained KCSA Strategic Communications to support the Company's strategic communications and investor relations efforts in the United States. KCSA will implement a comprehensive communications program aimed at further increasing awareness of Aurora across the U.S. institutional and retail investment communities. Since its inception nearly fifty years ago, KCSA has developed a strong reputation for its work representing public companies, including a growing roster of cannabis companies. The Company issued a total of 182,853 common shares of the Company to the vendors of CanvasRx for the achievement of certain performance milestones, pursuant to a share purchase agreement announced on August 10, 2016.

06:53 EDT Foot Locker provides store base update - During Q1, Foot Locker opened 11 new stores, remodeled or relocated 43 stores, and closed 37 stores. As of May 5, 2018, the Company operated 3,284 stores in 24 countries in North America, Europe, Australia, and New Zealand. In addition, 105 franchised Foot Locker stores were operating in the Middle East, as well as 11 franchised Runners Point stores in Germany.

06:51 EDT Foot Locker backs FY18 SSS guidance of positive growth - "The flow of premium product continues to improve, with increasing breadth and depth in the most sought after styles from our key vendors," said Richard Johnson, Chairman and CEO. "This led to Q1 results which were above our expectations. With the strength of our strategic vendor partnerships and our central position in youth culture, we continue to believe that we are poised to inflect to positive comparable-store sales growth as we progress through the year."

06:40 EDT DPW Holdings acquires minority interest in Manhattan luxury hotel development - DPW Holdings acquired a minority interest in a partnership that intends to construct a five-star ultra-luxury Manhattan hotel development, investing alongside venerable New York real estate development companies, Mactaggart Family & Partners and Caspi Development. To maximize long-term predictable cash flow for DPW, the investment will be made in a project with consistently strong luxury hospitality fundamentals, unique location advantages, and on terms pari-passu with New York City real estate investors. DPW expects the property to form a long-term anchor of its hospitality assets. The sponsor has signed a long-term contract with a 106-year, premier European hospitality group, which will share its flagship hotel's name and service with the 96 room Tribeca hotel. The sponsor expects to reveal the group as part of a branding effort that will commence in the fall of 2018.The sponsor has engaged AECOM Tishman Construction for the hotel's construction which broke ground in December 2017 and is expected to be completed during the summer of 2020, with the opening anticipated to be immediately thereafter. Based on a projected average daily rate, or ADR, of $983 upon stabilization in 2021, the project is expected to produce a stable, unlevered yield on cost of 10%. A refinancing, three years after opening, is projected to return 50% of the invested equity and should generate cash-on-cash returns of 18% thereafter. The 94,000 square foot hotel, located one block east of the Hudson River, will feature 96 rooms and suites, a full-service spa and six food and beverage venues, all designed by Martin Brudnizki Design Studio and Stephen B. Jacobs Group.

06:05 EDT Keryx presents data from ferric citrate trial in patients with CKD at ERA/EDTA - Keryx announced that data from an investigator sponsored study that evaluated the use of ferric citrate in patients with advanced chronic kidney disease, or CKD, was presented as a late-breaking oral presentation at the 55th annual ERA/EDTA congress in Copenhagen. The open-label, single-center study evaluated use of ferric citrate compared to standard of care treatment, or SOC, in late-stage non-dialysis dependent CKD patients. Patients with eGFR who were not anticipated to start renal replacement therapy within 8 weeks of study initiation were randomized 2:1 to receive a fixed dose of ferric citrate or SOC. The data presented are based on the 199 evaluable patients who were seen for at least one follow up visit. Of those randomized to the standard of care arm, 37% received phosphate binders during the pre-dialysis period. Patients enrolled in the study were seen monthly for 9 months, or, for those who started dialysis treatment, for three months post dialysis initiation. The data presented are related to the non-dialysis period of the study.

05:25 EDT First Data sells card processing businesses in parts of Central, Southeastern EU - SIA, a European high-tech leader in payment infrastructure and services, and First Data, have signed an agreement for SIA to acquire First Data's card processing businesses in parts of Central and Southeastern Europe for EUR 375M. In 2017, these businesses generated a combined revenue of approximately EUR 100M for First Data. This acquisition by SIA provides card processing, card production, call center and back-office services, including 13.3 million payment cards, 1.4 billion transactions, in addition to the management of POS terminals and ATMs. These businesses are primarily located in 7 countries: Greece, Croatia, Czech Republic, Hungary, Romania, Serbia and Slovakia. As a result of the transaction, SIA will become a leading player in processing and services in the region. The agreement includes the transfer of about 1,400 First Data employees into SIA.

05:20 EDT Northern Dynasty, First Quantum Minerals terminate framework agreement - Northern Dynasty Minerals advises that Northern Dynasty and First Quantum Minerals have been unable to reach agreement on the option and partnership transaction contemplated in the December 15, 2017 framework agreement between the parties. As such, the Framework Agreement has been terminated in accordance with its terms.